Streetbeat News

Partnerships

NVDA

TSM

Nvidia announced that TSMC is moving to production with Nvidia's computational lithography platform, Culitho. This collaboration is expected to enhance TSMC's chip manufacturing capabilities.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:23 pm

MSOS

Chicago Atlantic's Managing Partner, Peter Sack, discusses the potential transformational impact of a new development in the cannabis sector. The news hints at the involvement of MSOS, a cannabis-focused ETF, which could be positively affected by these changes.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:15 pm

GOOGL

NVDA

Google has announced the availability of Nvidia's Network Interface Module (NIM) on Google Kubernetes Engine, enhancing its cloud services with Nvidia's advanced technology.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:13 pm

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) shares rose by 1.18% to $0.14 after securing a $34 million research collaboration contract with X-Chem, funded by the U.S. Department of Defense. The collaboration aims to advance the TNX-4200 antiviral program using AI and machine learning.

Portfolio Pulse from Henry Khederian

October 08, 2024 | 2:57 pm

EWW

FXI

Mexico aims to reduce its reliance on Chinese imports by encouraging U.S. companies and other global manufacturers to produce goods locally. This move is part of a strategy to strengthen domestic supply chains amid rising trade tensions between the U.S. and China.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:55 pm

GK

MSOS

Investor Ross Gerber of Gerber Kawasaki expresses interest in working with cannabis companies once legalization occurs. He aims to position his firm as a key investment partner in the cannabis industry, highlighting the interest of young investors in this sector.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:40 pm

MRK

Mestag Therapeutics has entered a collaboration with MSD (Merck & Co., Inc.) to identify novel targets for inflammatory disease therapies using Mestag's RAFT platform. Mestag will receive payments potentially totaling $1.9 billion.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:39 pm

VINC

Vincerx Pharma (NASDAQ:VINC) is seeking a development partner for its early-stage blood cancer candidates, VIP236 and enitociclib, while focusing on its lead ADC, VIP943. The company shared updates on its Phase 1 studies, showing promising results for VIP943 and VIP236. VINC stock is down 25.3% at $0.52.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 2:38 pm

FXI

SPY

China's Commerce Minister and U.S. Secretary Raimondo had a phone call discussing economic and trade relations. Both sides expressed willingness to work together to improve the relationship, having candid and practical discussions on mutual concerns.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:09 pm

PPG

PPG has entered a strategic agreement with Shaw Industries to offer its resinous flooring products through Shaw's Patcraft brand, targeting the commercial property market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:05 pm